1stOncology™: Cancer Intelligence Service – Page 14380 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Perrigo To Release Third Quarter Calendar Year 2018 Financial Results On November 8, 2018

On October 25, 2018 Perrigo Company plc (NYSE; TASE: PRGO) reported that it will release its third quarter calendar year 2018 financial results on Thursday, November 8, 2018 (Press release, Perrigo Company, OCT 25, 2018, View Source [SID1234530299]). The Company will host a conference call beginning at 8:30 a.m. (EST).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

The conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at View Source or by phone at 888-317-6003, International 412-317-6061, and reference ID # 4651574. A taped replay of the call will be available beginning at approximately 12:00 p.m. (EST) Thursday, November 8, until midnight November 15, 2018. To listen to the replay, dial 877-344-7529, International 412-317-0088, and use access code 10125751.

MannKind Corporation to Hold 2018 Third Quarter Financial Results Conference Call on November 1, 2018

On October 25, 2018 MannKind Corporation (Nasdaq: MNKD) reported that it will host a conference call to discuss the 2018 third quarter and year-to-date financial results and other corporate developments at 9:00 AM (Eastern Time) on Thursday, November 1, 2018 (Press release, Mannkind, OCT 25, 2018, View Source [SID1234530189]).

Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder.

To view and listen to the earnings call webcast live via the Internet, visit the Company’s website at www.mannkindcorp.com and click on the "Q3 2018 MannKind Earnings Conference Call" link in the Webcasts section of News & Events. To participate in the live call by telephone, please dial (888) 394-8218 toll-free or (323) 701-0225 toll/international and use the conference passcode: 566425.

A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (844) 512-2921 toll-free or (412) 317-6671 toll/international and use the replay passcode: 5666425. A replay will also be available on MannKind’s website for 14 days.

Eagle Pharmaceuticals, Inc. to Discuss Third Quarter 2018 Financial Results on November 1, 2018

On October 25, 2018 Eagle Pharmaceuticals, Inc. ("Eagle" or "the Company") (Nasdaq:EGRX) reported that the Company will release its 2018 third quarter financial results on Thursday, November 1, 2018, before the market opens (Press release, Eagle Pharmaceuticals, OCT 25, 2018, View Source [SID1234530288]).

Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will host a conference call to discuss the results as follows:

Date Thursday, November 1, 2018
Time 8:30 a.m. EDT
Toll free (U.S.) 877-876-9173
International 785-424-1669
Webcast (live and replay)
www.eagleus.com, under the "Investor Relations" section

A replay of the conference call will be available for one week after the call’s completion by dialing 800-839-2459 (US) or 402-220-7218 (International) and entering conference call ID EGRXQ318. The webcast will be archived for 30 days at the aforementioned URL.

Pacira to Report Third Quarter 2018 Financial Results on Thursday November 1, 2018

On October 25, 2018 Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) reported that it will report its third quarter financial results before the open of the U.S. markets on Thursday, November 1, 2018 (Press release, Pacira Pharmaceuticals, OCT 25, 2018, View Source;p=RssLanding&cat=news&id=2373427 [SID1234530284]). Following the release, the company will host a live conference call and webcast at 8:30 a.m. ET.

To participate in the conference call, dial 1-877-845-0779 and provide the passcode 1988603. International callers may dial 1-720-545-0035 and use the same passcode. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the "Events" page on the Pacira website at investor.pacira.com.

For those unable to participate in the live call, a replay will be available at 1-855-859-2056 (domestic) or 1-404-537-3406 (international) using the passcode 1988603. The replay of the call will be available for one week from the date of the live call. The webcast will be available on the Pacira website for approximately two weeks following the call.

RedHill Biopharma to Present at the BIO-Europe 2018 Conference

On October 25, 2018 RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal diseases, reported that Mr. Adi Frish, Senior VP Business Development and Licensing, will present a corporate overview at the BIO-Europe 2018 Conference, on Tuesday, November 6, 2018, at 4:15 p.m. CET, at the Bella Center in Copenhagen, Denmark (Press release, RedHill Biopharma, OCT 25, 2018, View Source [SID1234530282]).

A copy of the presentation to be delivered by Mr. Frish will be available on the Company’s website and may be viewed at: View Source